[Growth factors in pancreatic cancer: the key to new therapy concepts for the future?].
Friess
H
H
Abteilung für Allgemeine Chirurgie, Universität Ulm.
Büchler
M
M
D018270:Carcinoma, Ductal, Breast / Q000235:genetics* / Q000628:therapy; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D005544:Forecasting; D015972:Gene Expression Regulation, Neoplastic / Q000502:physiology; D006131:Growth Inhibitors / Q000627:therapeutic use; D006801:Humans; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000628:therapy; D011518:Proto-Oncogene Proteins / Q000037:antagonists & inhibitors / Q000235:genetics*; D020893:Receptor, ErbB-3; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000235:genetics*
D006131:Growth Inhibitors; D011518:Proto-Oncogene Proteins; D014157:Transcription Factors; D066246:ErbB Receptors; D020893:Receptor, ErbB-3
Wachstumsfaktoren beim Pankreaskarzinom: Schlüssel für neue Therapiekonzepte der Zukunft?